参考文献/References:
[1]Gurunathan A,Ricci K,Iacobas I,et al. Impact of vascular anomalies on the PTEN phenotype in children and young adults[J]. Pediatr Blood Cancer,2020,67(6):e28258.
[2]Niethamer TK,Bush JO. Getting direction(s):the Eph/ephrin signaling system in cell positioning[J]. Dev Biol,2019,447(1):42-57.
[3]Su SA,Xie Y,Zhang Y,et al. Essential roles of EphrinB2 in mammalian heart:from development to diseases[J]. Cell Commun Signal,2019,17(1):29.
[4]Yang D,Jin C,Ma H,et al. EphrinB2/EphB4 pathway in postnatal angiogenesis:a potential therapeutic target for ischemic cardiovascular disease[J].Angiogenesis, 2016,19(3):297-309.
[5]Tsakiroglou P,VandenAkker NE,Del Bo’C,et al. Role of berry anthocyanins and phenolic acids on cell migration and angiogenesis:an updated overview[J]. Nutrients,2019,11(5):1075.
[6]Luxán G,Stewen J,Díaz N,et al. Endothelial EphB4 maintains vascular integrity and transport function in adult heart[J]. Elife,2019,8:e45863.
[7]Chen K,Bai H,Liu Y,et al. EphB4 forward-signaling regulates cardiac progenitor development in mouse ES cells[J]. J Cell Biochem,2015,116(3):467-475.
[8]Park I,Lee HS. EphB/ephrinB signaling in cell adhesion and migration[J]. Mol Cells,2015,38(1):14-19.
[9]Gucciardo E,Sugiyama N,Lehti K. Eph- and ephrin -dependent mechanisms in tumor and stem cell dynamics[J]. Cell Mol Life Sci,2014,71(19):3685-3710.
[10]Pitulescu ME,Schmidt I,Giaimo BD,et al. Dll4 and Notch signalling couples sprouting angiogenesis and artery formation[J]. Nat Cell Biol,2017,19(8):915-927.
[11]Yuan C,Wang P,Zhu S,et al. Overexpression of ephrinB2 in stem cells from apical papilla accelerates angiogenesis[J]. Oral Dis,2019,25(3):848-859.
[12]Cao C,Huang Y,Tang Q,et al. Bidirectional juxtacrine ephrinB2/Ephs signaling promotes angiogenesis of ECs and maintains self-renewal of MSCs[J]. Biomaterials, 2018,172:1-13.
[13]Ho VC,Fong GH. Vasculogenesis and angiogenesis in VEGF receptor-1 deficient mice[J]. Methods Mol Biol,2015,1332:161-176.
[14]Groppa E,Brkic S,Uccelli A,et al. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF[J]. EMBO Rep,2018,19(5):e45054.
[15]Gong T,Xu J,Heng B,et al. EphrinB2/EphB4 signaling regulates DPSCs to induce sprouting angiogenesis of endothelial cells[J]. J Dent Res,2019,98(7):803-812.
[16]Chen D,Teng JM,North PE,et al. RASA1-dependent cellular export of collagen Ⅳ controls blood and lymphatic vascular development[J]. J Clin Invest, 2019,129(9):3545-3561.
[17]Xiao H,Huang Q,Wang JQ,et al. Effect of ephrin-B2 on the expressions of angiopoietin-1 and -2 after focal cerebral ischemia/reperfusion[J]. Neural Regen Res,2016,11(11):1784-1789.
[18]Buckens OJ,El Hassouni B,Giovannetti E,et al. The role of Eph receptors in cancer and how to target them:novel approaches in cancer treatment[J]. Expert Opin Investig Drugs,2020,29(6):567-582.
[19]Cheng N,Brantley DM,Liu H,et al. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis[J]. Mol Cancer Res,2002,1(1):2-11.
[20]Torres MJ,McLaughlin KL,Renegar RH,et al. Intracardiac administration of ephrinA1-Fc preserves mitochondrial bioenergetics during acute ischemia/reperfusion injury[J]. Life Sci,2019,239:117053.
[21]Le MNT,Hasegawa K. Expansion culture of human pluripotent stem cells and production of cardiomyocytes[J]. Bioengineering (Basel),2019,6(2):48.
[22]Kemmerling N,Wunderlich P,Theil S,et al. Intramembranous processing by γ-secretase regulates reverse signaling of ephrin-B2 in migration of microglia[J]. Glia,2017,65(7):1103-1118.
[23]Barquilla A,Pasquale EB. Eph receptors and ephrins:therapeutic opportunities[J]. Annu Rev Pharmacol Toxicol,2015,55:465-487.
[24]Protack CD,Foster TR,Hashimoto T,et al. Eph-B4 regulates adaptive venous remodeling to improve arteriovenous fistula patency[J]. Sci Rep,2017,7(1):15386.
[25]Zheng LC,Wang XQ,Lu K,et al. Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells[J]. Oncotarget, 2017,8(25):41348-41363.
相似文献/References:
[1]宋林声,综述,陆地,等.低剂量多巴酚丁胺负荷磁共振成像在缺血性心脏病中的应用研究[J].心血管病学进展,2016,(3):285.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.018]
SONG Linsheng,LU Di,ZHAO Xinxiang.Low-dose Dobutamine Stress MRI Myocardial Perfusion and
Assessment of Myocardial Viability[J].Advances in Cardiovascular Diseases,2016,(2):285.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.018]
[2]翟恒博,综述,刘俊,等.缺血性心脏病再认识[J].心血管病学进展,2016,(4):395.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.018]
ZHAI Hengbo,LIU Jun.Rethinking of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(2):395.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.018]
[3]肖轶 余国龙.不同干细胞来源的外泌体在缺血性心脏病中的促血管新生作用[J].心血管病学进展,2022,(4):293.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.002]
XIAO Yi,YU Guolong?/html>.Application of Exosomes Derived from Various Stem Cells?n Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2022,(2):293.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.002]
[4]琚敏 汪蕾 宋雷 方纬.心脏交感神经显像的临床应用和研究进展[J].心血管病学进展,2023,(1):16.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.005]
JU Min,WANG Lei,SONG Lei,et al.Clinical Application and Research Progress of Cardiac Sympathetic Imaging[J].Advances in Cardiovascular Diseases,2023,(2):16.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.005]